Stock Market & Financial News
Should You Buy Alpine Income (PINE) After Golden Cross?
From a technical perspective, Alpine Income Property Trust, Inc. (PINE) is looking like an interesting pick, as it just reached a key level of support. PINE's 50-day simple moving average crossed above its 200-day simple moving average, which is known as a "golden cross" in the trading world.
Does Tetra (TTEK) Have the Potential to Rally 26.27% as Wall Street Analysts Expect?
The mean of analysts' price targets for Tetra (TTEK) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Think EverQuote (EVER) Could Surge 26.01%: Read This Before Placing a Bet
The consensus price target hints at a 26% upside potential for EverQuote (EVER). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
How Much Upside is Left in Royal Gold (RGLD)? Wall Street Analysts Think 26%
The mean of analysts' price targets for Royal Gold (RGLD) points to a 26% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Does CorMedix (CRMD) Have the Potential to Rally 68.74% as Wall Street Analysts Expect?
The mean of analysts' price targets for CorMedix (CRMD) points to a 68.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Home Depot issues cautious preliminary guidance for 2026
Home Depot Inc (NYSE:HD, XETRA:HDI) on Tuesday issued preliminary guidance for fiscal 2026 on Tuesday, signaling a cautious outlook amid a slow housing market. The company projects comparable sales growth of flat to 2%, total sales growth of 2.5% to 4.5%, operating margins of 12.4% to 12.6%, and diluted earnings per share (EPS) growth of flat to 4%.
Intuitive Machines: Great Story, Wrong Price After 22% Surge In Recent Days
Intuitive Machines (LUNR) is evolving into a full-service space contractor after acquiring Lanteris Space Systems, expanding capabilities across all major orbital regimes. LUNR shares are down 36% year to date, despite recent momentum with a 22% surge over five days around November 21. SA's quant model rates LUNR a Sell due to sector-lagging profitability and declining earnings estimates, contrasting with Wall Street's Strong Buy consensus.
Salesforce: When AI Disruption Fears Become A Golden Buying Opportunity
Salesforce (CRM) remains a Buy, with the market underappreciating its profitable growth and resilience amid AI disruption fears. CRM's topline growth guidance of 9–10% lags AI peers, but its focus on profitability and improving margins is increasingly pivotal. Agentforce + Data 360 ARR surpassed $1.4B, up over 100%, signaling healthy adoption of Salesforce's AI-driven initiatives.
Will Customer Defections Crumble Marvell Technology's AI Empire?
Marvell Technology ‘s ( NASDAQ:MRVL ) stock tumbled 7% yesterday, erasing recent gains on increasing investor jitters about its position in the artificial intelligence (AI) chip sector.
Here's Why Applied Materials (AMAT) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why ATI (ATI) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Astera Labs, Inc. (ALAB) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Fortinet (FTNT) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Ross Stores (ROST) is a Top Momentum Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why VALE S.A. (VALE) is a Top Momentum Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Navitas Semiconductor Soars 172% YTD: Is the Stock Still Worth Buying?
NVTS skyrockets 172% YTD as demand for its GaN and SiC chips grows alongside new AI data center power architectures.
Here's Why BJ's Wholesale Club (BJ) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Edison International (EIX) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Emcor Group (EME) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Blackbaud (BLKB) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Alphabet (GOOGL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Halozyme Therapeutics (HALO) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Flowserve (FLS) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ICICI Bank Limited (IBN) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Tyler Technologies (TYL) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Interactive Brokers Group, Inc. (IBKR) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fuel For Thought: The Bullish Case For NANO Nuclear Energy Among Speculators
Nano Nuclear Energy surged post-IPO, driven by investor enthusiasm for AI-related clean energy solutions. The stock experienced sharp declines after an announcement of a $400M private placement triggered dilution concerns and sector-wide profit-taking. As a pre-revenue company, it is valued on speculative future growth.
Pfizer: The Most Powerful Drug Pipeline In Pharma Could Deliver Major Long-Term Gains
Pfizer (PFE) is reiterated as a Buy, supported by the world's largest drug pipeline and trading below intrinsic value, despite near-term headwinds. PFE maintains strong free cash flow and improved guidance, targeting $61–$64 billion in 2025 revenue and $3–$3.15 adjusted EPS, while managing leverage post-acquisitions. Patent expirations threaten $17–$18 billion in annual revenue by 2026–2028, but aggressive acquisitions, R&D investments and cost savings aim to offset losses and drive long-term growth.
